Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maruishi PharmafiledCriticalMaruishi Pharma
Priority to MYPI2016001945ApriorityCriticalpatent/MY173829A/en
Priority claimed from PCT/JP2014/067023external-prioritypatent/WO2015198456A1/en
Publication of MY173829ApublicationCriticalpatent/MY173829A/en
The present invention provides a rocuronium preparation with an excellent stability. The rocuronium preparation contains rocuronium and a buffer solution and having an adjusted pH of 3.5 or less (for example, 2.5 to 3.5). The buffer solution may be a citric acid-sodium hydroxide buffer solution, a tartaric acid-sodium hydroxide buffer solution, a potassium hydrogen phthalate-hydrochloric acid buffer solution, a glycine-hydrochloric acid buffer solution, or the like. Such a rocuronium preparation has, for example, after 6-month storage at 40?C, a generation rate of rocuronium-related substance C of 5% or less.
MYPI2016001945A2014-06-262014-06-26Rocuronium preparation with improved stability
MY173829A
(en)